Logo image of ANTM

Anthem Inc (ANTM) Stock Fundamental Analysis

NYSE:ANTM - New York Stock Exchange, Inc. - US0367521038 - Common Stock

482.58  +12.71 (+2.71%)

After market: 482.58 0 (0%)

Fundamental Rating

2

Taking everything into account, ANTM scores 2 out of 10 in our fundamental rating. ANTM was compared to 102 industry peers in the Health Care Providers & Services industry. ANTM has a bad profitability rating. Also its financial health evaluation is rather negative. ANTM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ANTM was profitable.
ANTM Yearly Net Income VS EBIT VS OCF VS FCFANTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B 8B 10B

1.2 Ratios

Industry RankSector Rank
ROA 6.21%
ROE 17.36%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ANTM Yearly ROA, ROE, ROICANTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 5 10 15

1.3 Margins

The Operating Margin and Gross Margin are not available for ANTM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 4.33%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ANTM Yearly Profit, Operating, Gross MarginsANTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2 4 6

More info and screens

1

2. Health

2.1 Basic Checks

ANTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ANTM has less shares outstanding
Compared to 1 year ago, ANTM has a worse debt to assets ratio.
ANTM Yearly Shares OutstandingANTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M
ANTM Yearly Total Debt VS Total AssetsANTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 20B 40B 60B 80B

2.2 Solvency

A Debt/Equity ratio of 0.55 indicates that ANTM is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC6.49%
ANTM Yearly LT Debt VS Equity VS FCFANTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

5

3. Growth

3.1 Past

ANTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.56%, which is quite good.
The Earnings Per Share has been growing by 18.75% on average over the past years. This is quite good.
ANTM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.87%.
The Revenue has been growing by 10.28% on average over the past years. This is quite good.
EPS 1Y (TTM)18.56%
EPS 3Y17.74%
EPS 5Y18.75%
EPS Q2Q%17.69%
Revenue 1Y (TTM)15.87%
Revenue growth 3Y14.59%
Revenue growth 5Y10.28%
Sales Q2Q%17.63%

3.2 Future

The Earnings Per Share is expected to grow by 12.81% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.87% on average over the next years.
EPS Next Y12.48%
EPS Next 2Y12.93%
EPS Next 3Y13.13%
EPS Next 5Y12.81%
Revenue Next Year11.63%
Revenue Next 2Y8.34%
Revenue Next 3Y8.01%
Revenue Next 5Y6.87%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ANTM Yearly Revenue VS EstimatesANTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50B 100B 150B
ANTM Yearly EPS VS EstimatesANTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10 20 30 40

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ANTM is valuated rather expensively with a Price/Earnings ratio of 17.74.
When comparing the Price/Earnings ratio of ANTM to the average of the S&P500 Index (28.10), we can say ANTM is valued slightly cheaper.
ANTM is valuated correctly with a Price/Forward Earnings ratio of 14.57.
When comparing the Price/Forward Earnings ratio of ANTM to the average of the S&P500 Index (20.74), we can say ANTM is valued slightly cheaper.
Industry RankSector Rank
PE 17.74
Fwd PE 14.57
ANTM Price Earnings VS Forward Price EarningsANTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.45
ANTM Per share dataANTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400 500

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ANTM's earnings are expected to grow with 13.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.42
PEG (5Y)0.95
EPS Next 2Y12.93%
EPS Next 3Y13.13%

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.09%, ANTM has a reasonable but not impressive dividend return.
With a Dividend Yield of 1.09, ANTM pays less dividend than the S&P500 average, which is at 2.43.
Industry RankSector Rank
Dividend Yield 1.09%

5.2 History

On average, the dividend of ANTM grows each year by 14.64%, which is quite nice.
ANTM has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)14.64%
Div Incr YearsN/A
Div Non Decr YearsN/A
ANTM Yearly Dividends per shareANTM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 1 2 3 4

5.3 Sustainability

18.19% of the earnings are spent on dividend by ANTM. This is a low number and sustainable payout ratio.
ANTM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP18.19%
EPS Next 2Y12.93%
EPS Next 3Y13.13%
ANTM Yearly Income VS Free CF VS DividendANTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B 8B
ANTM Dividend Payout.ANTM Dividend Payout, showing the Payout Ratio.ANTM Dividend Payout.PayoutRetained Earnings

More info and screens

Anthem Inc

NYSE:ANTM (6/27/2022, 8:17:50 PM)

After market: 482.58 0 (0%)

482.58

+12.71 (+2.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-20 2022-04-20/bmo
Earnings (Next)07-20 2022-07-20/bmo
Inst Owners85.04%
Inst Owner Change0.61%
Ins Owners0.23%
Ins Owner Change0%
Market Cap116.34B
Analysts81.29
Price Target576.53 (19.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.09%
Yearly Dividend4.52
Dividend Growth(5Y)14.64%
DP18.19%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.74
Fwd PE 14.57
P/S 0.81
P/FCF N/A
P/OCF N/A
P/B 3.23
P/tB N/A
EV/EBITDA 12.45
EPS(TTM)27.21
EY5.64%
EPS(NY)33.12
Fwd EY6.86%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS598.75
BVpS149.22
TBVpSN/A
PEG (NY)1.42
PEG (5Y)0.95
Profitability
Industry RankSector Rank
ROA 6.21%
ROE 17.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 4.33%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC6.49%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.56%
EPS 3Y17.74%
EPS 5Y18.75%
EPS Q2Q%17.69%
EPS Next Y12.48%
EPS Next 2Y12.93%
EPS Next 3Y13.13%
EPS Next 5Y12.81%
Revenue 1Y (TTM)15.87%
Revenue growth 3Y14.59%
Revenue growth 5Y10.28%
Sales Q2Q%17.63%
Revenue Next Year11.63%
Revenue Next 2Y8.34%
Revenue Next 3Y8.01%
Revenue Next 5Y6.87%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A